Odulimomab
From Self-sufficiency
Revision as of 13:52, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Template:Infobox drug/mab source |
Target | CD11a |
Identifiers | |
CAS Number | 159445-64-4 |
ATC code | none |
Odulimomab is an investigational drug for the prevention of transplant rejection[1][2] and for the treatment of various immunological diseases[3][4].
It is a mouse monoclonal antibody directed against the alpha chain of the protein lymphocyte function-associated antigen 1 which is involved in immune reactions.[1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
- ↑ 1.0 1.1 Martin, X; Da Silva, M; Virieux, SR; Hadj Aissa, A; Buffet, R; Tiollier, J; Dubernard, JM (2000). "Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation". Transplantation proceedings. 32 (2): 481. doi:10.1016/S0041-1345(00)00849-6. PMID 10715487.
- ↑ Crétolle-Vastel, C; Camby, C; Cerf-Bensussan, N; Cavazzana-Calvo, M; Fischer, A; Révillon, Y; Sarnacki, S (1999). "Role of calcineurin-dependent drugs on the immunosuppressive effect induced by the anti-LFA-1 antibody in a fetal intestinal transplantation model in mice". Chirurgie; memoires de l'Academie de chirurgie. 124 (5): 503–10. PMID 10615777.
- ↑ Whitcup, SM; Chan, CC; Kozhich, AT; Magone, MT (1999). "Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis". Clinical immunology (Orlando, Fla.). 93 (2): 107–13. doi:10.1006/clim.1999.4775. PMID 10527686.
- ↑ Corbascio, M; Mahanty, H; Osterholm, C; Qi, Z; Pearson, TC; Larsen, CP; Freise, CE; Ekberg, H (2002). "Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice". Transplantation. 74 (1): 35–41. doi:10.1097/00007890-200207150-00007. PMID 12134096.
Categories:
- Pages with script errors
- Articles which use infobox templates with no data rows
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs